CD4 and Alzheimer disease: Downregulation of Ccl24 (eotaxin for eosinophils)[34] and Ccr8 (implicated as a skin‐homing receptor for CD4+/CD8+ T‐cells and leukocytes in AD[35]) could theoretically be beneficial in the context of chronic inflammation.